6/12/2014 5:31:45 AM
Pfizer Inc. (PFE) Chief Financial Officer Frank D’Amelio said the company’s $117 billion bid for AstraZeneca Plc (AZN) broke down over price.
Pfizer, the largest U.S. drugmaker, set a ceiling for how much it would pay for London-based AstraZeneca and wasn’t willing to go over that limit, D’Amelio said today at an investment conference organized by Goldman Sachs Group Inc. While New York-based Pfizer can approach AstraZeneca again after a U.K. regulatory period ends in six months, D’Amelio said he couldn’t comment about whether it will do so.
Help employers find you! Check out all the jobs and post your resume.
comments powered by